Ledger.Open graph →
SEC Form D · filed November 25, 2022

Thiogenesis Therapeutics, Corp

Offering
$218K
Sold
$218K
Exemption
Rule 506(b)
Industry
Other
Location
TORONTO, Ontario, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Brook G. Riggins · Toronto, Ontario, CanadaExec · DirectorChristopher G. Starr · Toronto, Ontario, CanadaDirectorPatrice G. Rioux · Toronto, Ontario, CanadaExec · DirectorRobert Dubeau · VANCOUVER, British Columbia, CanadaExec · DirectorKim G. Tsuchimoto · Toronto, Ontario, CanadaExec · DirectorKenneth Cotiamco · VANCOUVER, British Columbia, CanadaDirectorTryon Breytenbach · VANCOUVER, British Columbia, CanadaDirectorHogan W. Mullally · Toronto, Ontario, CanadaDirectorSteven Snow · West Hollywood, CAExec · DirectorCharles I. Smith · Little Rock, ARDirectorEzra Serrur · Brooklyn, NYExec · DirectorHound Partners, LLC · New York, NYDirectorHogan W. Mullally · Toronto, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗